- Home
- CMRE vs PHVS Comparison
CMRE vs PHVS Comparison
Compare CMRE & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRE
- PHVS
- Stock Information
- Founded
- CMRE 1974
- PHVS 2015
- Country
- CMRE Monaco
- PHVS Switzerland
- Employees
- CMRE N/A
- PHVS N/A
- Industry
- CMRE Marine Transportation
- PHVS Biotechnology: Pharmaceutical Preparations
- Sector
- CMRE Consumer Discretionary
- PHVS Health Care
- Exchange
- CMRE Nasdaq
- PHVS Nasdaq
- Market Cap
- CMRE 1.3B
- PHVS 1.3B
- IPO Year
- CMRE 2010
- PHVS 2021
- Fundamental
- Price
- CMRE $12.60
- PHVS $23.38
- Analyst Decision
- CMRE Hold
- PHVS Strong Buy
- Analyst Count
- CMRE 1
- PHVS 5
- Target Price
- CMRE $13.00
- PHVS $35.60
- AVG Volume (30 Days)
- CMRE 440.3K
- PHVS 123.8K
- Earning Date
- CMRE 10-31-2025
- PHVS 11-12-2025
- Dividend Yield
- CMRE 3.65%
- PHVS N/A
- EPS Growth
- CMRE N/A
- PHVS N/A
- EPS
- CMRE 2.37
- PHVS N/A
- Revenue
- CMRE $2,085,912,000.00
- PHVS N/A
- Revenue This Year
- CMRE N/A
- PHVS N/A
- Revenue Next Year
- CMRE N/A
- PHVS N/A
- P/E Ratio
- CMRE $4.68
- PHVS N/A
- Revenue Growth
- CMRE 56.37
- PHVS N/A
- 52 Week Low
- CMRE $6.02
- PHVS $11.51
- 52 Week High
- CMRE $12.66
- PHVS $26.33
- Technical
- Relative Strength Index (RSI)
- CMRE 74.81
- PHVS 55.19
- Support Level
- CMRE $12.00
- PHVS $23.20
- Resistance Level
- CMRE $12.33
- PHVS $24.83
- Average True Range (ATR)
- CMRE 0.27
- PHVS 1.34
- MACD
- CMRE 0.01
- PHVS -0.02
- Stochastic Oscillator
- CMRE 94.37
- PHVS 58.45
About CMRE Costamare Inc. $0.0001 par value
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.